Henry Schein, Inc. (HSIC) Earns “Hold” Rating from Stifel Nicolaus
Henry Schein, Inc. (NASDAQ:HSIC)‘s stock had its “hold” rating reaffirmed by research analysts at Stifel Nicolaus in a research note issued to investors on Thursday.
Several other analysts have also weighed in on HSIC. Piper Jaffray Companies began coverage on Henry Schein in a research note on Monday, June 12th. They issued a “neutral” rating and a $200.00 price objective on the stock. Barrington Research lifted their price target on Henry Schein from $196.00 to $198.00 and gave the company an “outperform” rating in a research note on Wednesday, May 10th. Zacks Investment Research lowered Henry Schein from a “buy” rating to a “hold” rating in a research note on Wednesday, May 31st. Craig Hallum started coverage on Henry Schein in a research note on Tuesday, April 11th. They set a “hold” rating on the stock. Finally, Deutsche Bank AG started coverage on Henry Schein in a research note on Wednesday, March 15th. They set a “hold” rating and a $174.00 price target on the stock. Ten investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $184.08.
Shares of Henry Schein (NASDAQ HSIC) traded down 1.40% on Thursday, reaching $181.11. 333,786 shares of the company traded hands. The company has a market capitalization of $14.37 billion, a P/E ratio of 27.52 and a beta of 1.09. The firm’s 50 day moving average is $182.32 and its 200 day moving average is $169.72. Henry Schein has a one year low of $146.23 and a one year high of $186.99.
Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, May 9th. The company reported $1.76 earnings per share for the quarter, beating the consensus estimate of $1.65 by $0.11. The business had revenue of $2.92 billion for the quarter, compared to analyst estimates of $2.83 billion. Henry Schein had a return on equity of 19.74% and a net margin of 4.53%. Henry Schein’s revenue was up 7.7% compared to the same quarter last year. During the same period last year, the firm posted $1.41 earnings per share. Analysts expect that Henry Schein will post $7.28 earnings per share for the current fiscal year.
WARNING: This piece of content was reported by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was stolen and reposted in violation of United States and international copyright & trademark laws. The correct version of this piece of content can be read at https://www.americanbankingnews.com/2017/07/06/henry-schein-inc-hsic-earns-hold-rating-from-stifel-nicolaus.html.
In other Henry Schein news, EVP Gerald A. Benjamin sold 12,578 shares of Henry Schein stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $175.10, for a total value of $2,202,407.80. Following the completion of the sale, the executive vice president now directly owns 44,061 shares in the company, valued at $7,715,081.10. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 1.27% of the company’s stock.
Large investors have recently modified their holdings of the company. Girard Partners LTD. increased its stake in shares of Henry Schein by 0.3% in the first quarter. Girard Partners LTD. now owns 3,115 shares of the company’s stock worth $529,000 after buying an additional 10 shares during the last quarter. Cleararc Capital Inc. increased its stake in shares of Henry Schein by 0.6% in the first quarter. Cleararc Capital Inc. now owns 1,950 shares of the company’s stock worth $331,000 after buying an additional 11 shares during the last quarter. Penserra Capital Management LLC increased its stake in shares of Henry Schein by 1.0% in the first quarter. Penserra Capital Management LLC now owns 1,518 shares of the company’s stock worth $258,000 after buying an additional 15 shares during the last quarter. Raymond James Financial Services Advisors Inc. increased its stake in shares of Henry Schein by 0.8% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 2,576 shares of the company’s stock worth $391,000 after buying an additional 21 shares during the last quarter. Finally, Wetherby Asset Management Inc. increased its stake in shares of Henry Schein by 0.7% in the first quarter. Wetherby Asset Management Inc. now owns 3,147 shares of the company’s stock worth $535,000 after buying an additional 21 shares during the last quarter. Institutional investors and hedge funds own 90.74% of the company’s stock.
Henry Schein Company Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.